# CTO Legends

> CTO Legends is Benjamin's independent website, operated by AVALON RESET LLC. Its creator-tip portal accepts voluntary commercial payments for creative content already provided.

Creator tips do not buy future content, services, membership, access, or special treatment. They are not charitable donations. There are one-time, monthly, and yearly choices. A verified email may have one monthly and one yearly subscription, plus repeat one-time payments. Existing recurring amounts change at the next renewal after confirmation in Stripe; each subscription can be canceled independently.

The payment dashboard requires provider-verified sign-in and recognized CTO membership. Analytics permission is a separate visitor choice. Browser Global Privacy Control keeps Google Analytics off. Agent tools cannot choose analytics consent, sign in, authorize payment, or cancel subscriptions. Stripe presents the payment and billing confirmation screens.

## Site and policies

- [Home and creator-tip dashboard](https://cto-legends.com/): Public entry and signed-in contribution flow.
- [Terms](https://cto-legends.com/terms): Authoritative commercial, billing, cancellation, and refund terms.
- [Privacy](https://cto-legends.com/privacy): Data handling and browser analytics controls.
- [Sitemap](https://cto-legends.com/sitemap.xml): Indexable public pages.

## Agent interfaces

- [Agent tools](https://cto-legends.com/agent-tools.json): Site-specific capability documentation, including WebMCP browser requirements. This is documentation, not a remote MCP endpoint.
- [Contribution catalogue](https://cto-legends.com/data/canonical-rung-product-map.json): Read-only current amounts and billing cadences; does not grant payment access.

WebMCP tools are progressive enhancements registered on the top-level homepage through document.modelContext in supporting browsers. Runtime availability depends on the browser and its experimental feature or origin-trial support. The ordinary website works without WebMCP. No search ranking or traffic benefit is asserted.